COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Vedolizumab Subcutaneous Long-Term Open-Label Extension Study

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02620046
Recruitment Status : Active, not recruiting
First Posted : December 2, 2015
Last Update Posted : March 13, 2020
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : August 11, 2021
Estimated Study Completion Date : February 10, 2022